Patient guide: Herceptin — for early breast cancer
Elspeth Kay with the PHARMAC award
‘PHARMAC is delighted at receiving an award for Herceptin — for early breast cancer in the 2007 WriteMark Plain English awards.
‘An important part of PHARMAC's work is promoting the best possible use of medicines. We produce a range of written materials that are intended to help people to make informed choices about medicines and to use them safely and effectively. We work hard to ensure that our writing is clear and concise and that we keep in mind the viewpoint of our readers. PHARMAC saw a particular need for a resource that sensitively communicated the complex Herceptin story for women who were making decisions about their breast cancer treatment. The WriteMark award is wonderful recognition of the work of everyone who contributes to writing, reviewing and testing our materials.’
Elspeth Kay, Project Manager, Access and Optimal Use — Te Whaioranga
PHARMAC